Specialty Pharmaceutical Company dedicated to patients living with chronic conditions

« Back

Document Details

Form
Filing Date
May 10, 2019
Document Date
May 9, 2019
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
BioDelivery Sciences International, Inc.
Issuer
BIODELIVERY SCIENCES INTERNATIONAL INC
BioDelivery Sciences Acquires U.S. Commercial Rights to Symproic®
Thank you. We will get back to you soon